BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17203992)

  • 21. Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines.
    Hildesheim A; Markowitz L; Avila MH; Franceschi S
    Vaccine; 2006 Aug; 24 Suppl 3():S3/227-32. PubMed ID: 16950011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HPV vaccination: principles, results and future perspectives].
    Rouzier R; Uzan C; Collinet P
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):13-8. PubMed ID: 17293248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV vaccine and males: issues and challenges.
    Zimet GD; Rosenthal SL
    Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fostering acceptance of human papillomavirus vaccines.
    Dekker AH
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S14-8. PubMed ID: 16729556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes.
    Brabin L; Roberts SA; Farzaneh F; Kitchener HC
    Vaccine; 2006 Apr; 24(16):3087-94. PubMed ID: 16500736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
    Mahoney MC
    J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against human papillomavirus.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):89-93. PubMed ID: 19056700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
    Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of general human papillomavirus vaccination in sexually active women].
    Hampl M
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S95-9. PubMed ID: 19353480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
    Villa LL
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlating immunity with protection for HPV infection.
    Frazer I
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus infection: the role of vaccination in pediatric patients.
    Nichols JR; Stovall SH; Jacobs RF
    Clin Pharmacol Ther; 2007 Apr; 81(4):607-10. PubMed ID: 17314926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the significance of the HPV epidemic?
    Anorlu RI
    Can J Urol; 2008 Feb; 15(1):3860-5. PubMed ID: 18304395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.